tositumomab and iodine I 131 tositumomab

Definition / meaning of tositumomab and iodine I 131 tositumomab

A combination of monoclonal antibodies used to treat certain types of non-Hodgkin lymphoma. The monoclonal antibody tositumomab is given with iodine I 131 tositumomab (a form of tositumomab that has been chemically changed by adding radioactive iodine). Monoclonal antibodies are made in the laboratory and can locate and bind to substances in the body, including cancer cells. Also called Bexxar regimen, iodine I 131 tositumomab, and tositumomab.

Listed under:

Find More About 'tositumomab and iodine I 131 tositumomab'

Source(s):

The Web site of the National Cancer Institute (http://www.cancer.gov/)

Leave a Comment

*

This site uses Akismet to reduce spam. Learn how your comment data is processed.